Sectors & IndustriesConsumer DefensivePharmaceutical Retailers

Best Pharmaceutical Retailer Stocks to Buy Now (2025)

Top pharmaceutical retailer stocks in 2025 ranked by overall Due Diligence Score. See the best pharmaceutical retailer stocks to buy now, according to analyst forecasts for the pharmaceutical retailers industry.

According to Due Diligence Score, the 3 best drug store stocks to buy right now are:

High Tide (NASDAQ:HITI) is the top pharmaceutical retailer stock with a Due Diligence Score of 36, which is 11 points higher than the pharmaceutical retailer industry average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. High Tide has seen its stock return 59.78% over the past year, overperforming other pharmaceutical retailer stocks by 101 percentage points.

High Tide has an average 1 year price target of $4.50, an upside of 59.57% from High Tide's current stock price of $2.82.

High Tide stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering High Tide, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Scienture Holdings (NASDAQ:SCNX) is the second best pharmaceutical retailer stock with a Due Diligence Score of 34, which is 9 points higher than the pharmaceutical retailer industry average of 25. It passed 10 out of 33 due diligence checks and has average fundamentals. Scienture Holdings has seen its stock lose -22.43% over the past year, overperforming other pharmaceutical retailer stocks by 19 percentage points.

Sunlink Health Systems (NYSEMKT:SSY) is the third best pharmaceutical retailer stock with a Due Diligence Score of 31, which is 6 points higher than the pharmaceutical retailer industry average of 25. It passed 9 out of 33 due diligence checks and has average fundamentals. Sunlink Health Systems has seen its stock lose -2.22% over the past year, overperforming other pharmaceutical retailer stocks by 39 percentage points.

Out of 1 pharmaceutical retailer stocks that have issued dividends in the past year, the 1 pharmaceutical retailer stocks with the highest dividend yields are:

Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 9.88%, which is 5 percentage points higher than the pharmaceutical retailer industry average of 4.94%. Walgreens Boots Alliance's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Walgreens Boots Alliance's dividend has not shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of -9.8% indicates that its high dividend yield might not be sustainable for the long-term.

Pharmaceutical retailer stocks were up 1.85% in the last day, and down -2.13% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are up.

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical retailer stocks right now are:

Scienture Holdings (NASDAQ:SCNX) is the most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Scienture Holdings has a valuation score of 43, which is 31 points higher than the pharmaceutical retailer industry average of 12. It passed 3 out of 7 valuation due diligence checks.

Scienture Holdings's stock has dropped -22.43% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 19 percentage points.

Walgreens Boots Alliance (NASDAQ:WBA) is the second most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Walgreens Boots Alliance has a valuation score of 14, which is 2 points higher than the pharmaceutical retailer industry average of 12. It passed 1 out of 7 valuation due diligence checks.

Walgreens Boots Alliance's stock has dropped -56.51% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -15 percentage points.

Sunlink Health Systems (NYSEMKT:SSY) is the third most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Sunlink Health Systems has a valuation score of 14, which is 2 points higher than the pharmaceutical retailer industry average of 12. It passed 1 out of 7 valuation due diligence checks.

Sunlink Health Systems's stock has dropped -2.22% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 39 percentage points.